Natco gets CDSCO nod for emergency use of Baricitinib tablets for COVID-19 treatment
Updated : May 03, 2021 01:45:09 IST
Baricitinib in combination with Remdesivir is used for treatment of COVID-19 positive patients, the company said.
The company is ready to launch the product this week.
Published : May 03, 2021 12:05 PM IST